Spokane Regional Health District to resume use of Johnson & Johnson COVID vaccine

Oregon: Cdc Investigating Woman’s Death After J&j Vaccine
David Zalubowski

FILE - This Saturday, March 6, 2021, file photo, shows vials of Johnson & Johnson COVID-19 vaccine at a hospital pharmacy. Oregon health officials said Thursday, April 22, 2021, that federal officials are investigating the death of a woman in her 50s who developed a rare blood clot and low platelets within two weeks of receiving the Johnson & Johnson vaccine.

SPOKANE, Wash. — The Spokane Regional Health District will resume use of the Johnson and Johnson COVID-19 vaccine. 

“The J&J vaccine is safe and effective,” said Interim Health Officer Dr. Frank Velazquez. “The risks are rare compared to the enormous morbidity and mortality risks associated with contracting the COVID-19 virus. It’s ease of use makes it instrumental in many of our vaccination outreach efforts.” 

Earlier this month, the US announced a pause on the J&J vaccine following a few reports of blood clots. The government uncovered 15 vaccine recipients who developed the highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died and seven were hospitalized. 

The 11-day federal pause was lifted on Friday, and on Saturday, Governor Jay Inslee announced J&J vaccinations would resume in Washington. 

The SRHD has been using J&J vaccines for individuals who are homebound, living in congregate settings and in rural communities. This vaccine has an ability to be stored at a warmer temperature and since it only requires one dose, itr allows for faster, more efficient vaccination in these communities. 

Some flu-like symptoms, such as tiredness, muscle pain, chills or fever after getting a vaccine are normal. Anyone who has received a J&J vaccine in the last three weeks should reach out to their healthcare provider if they experience severe headache, abdominal pain, leg pain or shortness of breath.

RELATED: US lifts pause, allowing J&J COVID-19 vaccinations to resume

READ: Johnson & Johnson vaccines will resume in Washington